Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001092799 | SCV001249456 | uncertain significance | not provided | 2022-10-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001092799 | SCV002300200 | uncertain significance | not provided | 2022-04-26 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 872373). This variant has not been reported in the literature in individuals affected with OPHN1-related conditions. This variant is present in population databases (rs367993068, gnomAD 0.001%), including at least one homozygous and/or hemizygous individual. This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 50 of the OPHN1 protein (p.Met50Val). |
Revvity Omics, |
RCV003132223 | SCV003814281 | uncertain significance | X-linked intellectual disability-cerebellar hypoplasia syndrome | 2020-12-20 | criteria provided, single submitter | clinical testing |